…Kimberly-Clark is buying Kenvue in a nearly $50 billion cash and stock deal…
Hey @Delta_V@lemmy.world I tried to reply to your PM but apparently you blocked me. LOL.
My GUESS is this post got removed for not technically being politics.
There’s definitely a political REASON Kenvue got purchased, but the story itself is probably more fit for !news@lemmy.world or !business@lemmy.world
The purchase price was historically low due to the libelous accusations of acetaminophen causing autism.
Investing in corruption pays off bigly when Republicans manage to ooze their way into office.
It suddenly makes sense why they said that about Tylenol.
And why they started rolling it all back.
Wow, I wonder if their share price dipped precipitously recently.
Kenvue spun out of Johnson & Johnson in May of 2023 and has had a rocky start. Its shares were down more than 30-percent since its IPO, but they are popping on this news. Kimberly-Clark shares meanwhile are sliding as investors digest the hefty price tag and weigh the debt and risks that come with a mega deal.
Bigger picture - this is just part of a trend: big consumer brands are bulking up to handle rising costs and slower growth, and if approved, this one could be one of the largest buyouts in U.S. consumer history.
For shoppers however, this could mean less competition in the aisles and potentially higher prices.
That’ll do it for your daily briefing. From the New York Stock Exchange, I’m Caroline Woods with TheStreet.
Bigger picture - this is just part of a trend: big consumer brands are bulking up to handle rising costs and slower growth
This is not the bigger picture. The bigger picture is that late stage capitalism endorses the belief that it’s more financially efficient to stomp out competition and innovation as a mechanism for increased revenue and profit through random price increase. That the consumer suffers is the willingly embraced side effect.



